KATHERINE REGAN: Open Payments
NPI 1891273710 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 9 payments from 5 companies in 2025. Trend: 2023 $446 · 2024 $825 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $318 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Legend Biotech USA Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Fabhalta, SCEMBLIX, ULTOMIRIS, CARVYKTI, Columvi, TECVAYLI.
Industry payments across TX — which companies pay providers there.
